Physician profile

Grant Chavin

Homewood, IL

NPI 1548284730

$13,902.62

in general payments reported to CMS, 2019-2025

50 companies · $2,180 in 2025

The $2,180 reported for 2025 was more than what 94% of providers received nationally.

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$6,402.85
Education$85.05

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Boston Scientific Corporation $1,521.02 2019-2025 Ams 700, General - Bph, Moses
Abbvie INC. $1,204.88 2019-2025 Botox, Lupron Depot
Sumitomo Pharma America, INC. $1,158.54 2023-2025 Gemtesa, Orgovyx
Astellas Pharma US INC $1,011.69 2019-2025 Xtandi, Myrbetriq, Padcev
Myriad Genetic Laboratories, INC. $932.26 2021-2025 Prolaris, Myrisk
Coloplast Corp $860.21 2019-2025 Speedicath
Janssen Biotech, INC. $549.86 2019-2024 Erleada
Bayer Healthcare Pharmaceuticals INC. $496.51 2019-2025
Allergan, INC. $491.09 2019-2022
Procept Biorobotics Corporation $443.78 2021-2025 Aquabeam Robotic System, Aquabeam System
Axonics, INC. $412.10 2021-2023 Axonics, Bulkamid
Dendreon Pharmaceuticals LLC $389.04 2019-2024 Provenge
Endo Pharmaceuticals INC. $380.25 2019-2023 Edex, Xiaflex, Aveed
Endo USA, INC. $365.63 2024-2025 Xiaflex, Aveed
Teleflex LLC $294.28 2021-2025 Urolift, Barrigel
Show all 50 companies
CompanyGeneral paymentsYearsTop products
Myovant Sciences INC. $268.77 2021-2022
Verity Pharmaceuticals INC. $258.58 2022-2024 Trelstar
Urovant Sciences INC $251.00 2021-2022
Merck Sharp & Dohme LLC $231.29 2021-2025 Keytruda, Lynparza, Keytruda Qlex
Calyxo, INC. $196.91 2025 Cvac Aspiration System
Ferring Pharmaceuticals INC. $193.90 2019-2025 Adstiladrin
Tempus Ai, INC $166.45 2024
Antares Pharma, INC. $161.53 2022-2025 Xyosted, Nocdurna, Tlando
Progenics Pharmaceuticals, INC. $159.13 2021-2025 Pylarify
Novartis Pharmaceuticals Corporation $155.37 2022-2025
Olympus America INC. $151.76 2019-2024 Itind System, Soltive
Blue Earth Diagnostics $147.32 2020-2022
Accord Healthcare, INC. $109.78 2023-2024
Convatec INC. $109.65 2020-2024
Urogen Pharma, INC. $81.31 2025
Zyla Life Sciences, INC. $65.73 2019
Pacira Pharmaceuticals Incorporated $61.94 2019-2024 Exparel
Caldera Medical, INC $57.13 2021
Pfizer INC. $54.55 2019-2024
Mission Pharmacal Company $50.38 2019-2022
Lantheus Medical Imaging, INC. $47.77 2024
Immunitybio, INC. $45.07 2024-2025
C. R. Bard, INC. & Subsidiaries $45.05 2020-2025 Bard Urinary Drainage Bag
Mimedx Group, INC. $43.32 2025
Halozyme INC $40.72 2023
Intuitive Surgical, INC. $40.00 2019
Integra Lifesciences Corporation $39.42 2022
Tolmar, INC. $38.22 2024
Davol INC. $24.12 2025 Arista
Bluewind Medical $19.81 2024 Revi
Astrazeneca Pharmaceuticals Lp $19.04 2021
Profound Medical Corp. $17.93 2025 Tulsa-Pro
Acerus Pharmaceuticals Corporation $16.74 2020
Metuchen Pharmaceuticals $12.63 2020
Healthtronics Stone Solutions, LLC $9.16 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Grant Chavin

$13,902.62

in general payments reported 2019-2025

Years
2019-2025
Top company
Boston Scientific Corporation
Context
The $2,180 reported for 2025 was more than what 94% of providers received nationally.

https://glasscript.com/doctor/114961/grant-chavin

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.